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Abstract
Background: Arterial hyperoxia may induce vasoconstriction and reduce cardiac output, which is particularly
undesirable in patients who already have compromised perfusion of vital organs. Due to the inaccessibility of vital
organs in humans, vasoconstrictive effects of hyperoxia have primarily been studied in animal models. However, the
results of these studies vary substantially. Here, we investigate the variation in magnitude of the hyperoxia effect
among studies and explore possible sources of heterogeneity, such as vascular region and animal species.
Method: Pubmed and Embase were searched for eligible studies up to November 2017. In vivo and ex vivo animal
studies reporting on vascular tone changes induced by local or systemic normobaric hyperoxia were included.
Experiments with co-interventions (e.g. disease or endothelium removal) or studies focusing on lung, brain or fetal
vasculature or the ductus arteriosus were not included. We extracted data pertaining to species, vascular region,
blood vessel characteristics and method of hyperoxia induction. Overall effect sizes were estimated with a
standardized mean difference (SMD) random effects model.
Results: We identified a total of 60 studies, which reported data on 67 in vivo and 18 ex vivo experiments. In the in
vivo studies, hyperoxia caused vasoconstriction with an SMD of − 1.42 (95% CI − 1.65 to − 1.19). Ex vivo, the overall
effect size was SMD − 0.56 (95% CI − 1.09 to − 0.03). Between-study heterogeneity (I2) was high for in vivo (72%,
95% CI 62 to 85%) and ex vivo studies (86%, 95% CI 78 to 98%). In vivo, in comparison to the overall effect size,
hyperoxic vasoconstriction was less pronounced in the intestines and skin (P = 0.03) but enhanced in the cremaster
muscle region (P < 0.001). Increased constriction was seen in vessels 15–25 μm in diameter. Hyperoxic constriction
appeared to be directly proportional to oxygen concentration. For ex vivo studies, heterogeneity could not be
explained with subgroup analysis.
Conclusion: The effect of hyperoxia on vascular tone is substantially higher in vivo than ex vivo. The magnitude of
the constriction is most pronounced in vessels ~ 15–25 μm in diameter and is proportional to the level of hyperoxia.
Relatively increased constriction was seen in muscle vasculature, while reduced constriction was seen in the skin and
intestines.
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Background
Superfluous oxygen supplementation in the acute, peri-
operative and intensive care setting frequently leads to
arterial hyperoxia [1–3] and is associated not only with
pulmonary side effects, but also with substantial acute
hemodynamic changes. Hyperoxia can increase systemic
vascular resistance due to (systemic) vasoconstriction
and reduce cardiac output.
Although increased systemic vascular resistance indi-
cates vasoconstriction, it does not inform in which organ
the constriction occurs or at which location in the arter-
ial tree. It is important for patient care to know whether
constriction occurs equally or preferentially in organs.
For instance, it may be argued that restriction of blood
flow to resting skeletal muscle is less consequential than
constriction in active cardiac muscle or organs like the
liver and kidney. In animals, a hyperoxia-induced redis-
tribution of blood flow to the kidney and splanchnic
area has been observed, suggesting that vessels in these
areas respond differently to hyperoxia [4–6].
Vascular diameter measurements in clinically relevant
organs (e.g. visceral organs) often require surgical inter-
vention. In humans, observations of hyperoxia-induced
changes in vessel diameter in the microcirculation are
therefore limited to superficial vascular beds such as the
retina [7–9] and the sublingual vascular bed [10]. These
organs are possibly not representative of hyperoxia-related
vessel diameter changes in critical organs. Consequently,
the effects of oxygen on vascular tone in deeper organs
have been studied predominantly in animal models, using
intravital microscopy (in vivo) and myography of isolated
arteries (ex vivo). However, the results of these studies
vary tremendously. Raising the oxygen tension to hyper-
oxic levels could lead to vasoconstriction [11–13], no ef-
fect [14–16] or even vasodilation [17, 18]. The causes of
this heterogeneity are unclear, but might include differences
between species, study methodology, vascular beds and/or
the location of the hyperoxia sensor (e.g. the vessel wall or
extravascular tissue). Identifying the source(s) of heterogen-
eity may contribute to a better understanding of the mecha-
nism(s) involved in hyperoxic vasoconstriction [19].
With this systematic review and meta-analysis, we aim
to provide an overview of the characteristics, quality and
outcomes of all animal studies on the effect of hyperoxia
on arteriolar tone, both in vivo and ex vivo. We also in-
vestigate the variation in magnitude of the hyperoxia ef-
fect among studies and explore sources of heterogeneity.
Methods
This review is reported according to the preferred
reporting items for systematic reviews and meta-analyses
(PRISMA) guidelines [20]. The review methodology was
specified in advance and documented using The
Systematic Review Centre for Laboratory Animal
Experimentation (SYRCLE) systematic review protocol
for animal intervention studies ([21] and Additional file 1)
and was registered on www.syrcle.nl on 22–02-2017. The
protocol describes separate strategies for in vivo and ex
vivo studies. However, due to considerable overlap and to
enhance readability, we have combined the description of
the review methodology where possible. The combined
review question was: what is the effect of normobaric
hyperoxia or hyperoxic superfusion on vascular tone of in
vivo and ex vivo arteries and arterioles, in comparison to
normoxia or normoxic superfusion?
Amendments to the review protocol
To assess the risk of bias in studies, we planned to use
the SYRCLE risk of bias tool. This tool has several items
that relate to studies in which separate intervention and
control groups are used. In such experiments, animal
housing and animal selection may have a significant im-
pact on outcomes. However, the studies included in this
review (both in vivo and ex vivo) were all short-term
pretest-posttest designs, performed in the same animal/
vessels (e.g. no control groups). As a consequence, the
SYRCLE risk of bias tool was not suitable for this review
and was substituted by a customized quality checklist
(see “Quality assessment” section). Due to the large vari-
ation in the size of the arteries investigated in the in vivo
experiments, we added artery size post hoc as a possible
source of heterogeneity (see “Data analysis”).
Search strategy
We searched the databases Pubmed and Embase for arti-
cles published from inception up to 22 November 2017.
The search strategy included various terms for vasocon-
striction, vasodilation and hyperoxia. These categories
were then combined with the AND operator and filtered
for animal studies with the SYRCLE animal filter [22,
23]. We did not apply any language or date restrictions.
Additional file 1 shows the search strategies used. We
also checked the reference lists of included studies and
relevant reviews for additional articles on hyperoxia that
were not identified in the initial search.
Selection of studies
Studies identified by the initial search were subjected to
3-phase screening, performed by two investigators (BS
and AS). In the first phase, titles were screened to ex-
clude studies not related to blood vessels or hyperoxia.
In the second phase, titles and abstracts of articles were
screened for eligibility based on the following predefined
inclusion criteria: (1) controlled studies with repeated
measures involving (2) adult healthy animals or isolated
arteries or arterioles from adult healthy animals, (3)
short-term normobaric, normocapnic hyperoxia in com-
parison with a normoxic control (see “Oxygenation
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definitions” for an explanation), (4) vessel diameter or
tension measurements reported. In case of doubt, the
full text of the publication was evaluated. Disagreements
were resolved by discussion (BS and AS). In phase 3,
full-text articles were assessed for final inclusion in more
detail, based on the following exclusion criteria: (1) case
reports, reviews and studies without an intervention, (2)
disease models or models focusing on the vascular beds
of the lung, brain or retina, the fetal vasculature or the
ductus arteriosus, (3) studies without a focus on vasor-
eactivity, (4) vessels preconditioned by hypoxia, an inter-
vention in the experimental design other than oxygen
(e.g. addition of CO2, endothelium removal) or long
term hyperoxia, (5) none of our predefined outcome
measures were reported. In particular, the brain was
excluded from analysis because it is known to possess
extensive mechanisms for the regulation of its perfusion,
therefore making it unsuitable for inclusion in
meta-analysis of other more comparable vasculatures.
Similarly, we excluded studies in non-healthy animals, to
reduce anticipated heterogeneity because of altered regu-
lation of perfusion during states of disease.
Oxygenation definitions
For the in vivo studies, when the intervention was ap-
plied systemically, the measurements while the animal
was breathing a gas with 20–21% O2 were considered as
normoxic. Consequently, measurements during the in-
halation of a gas with an oxygen content > 21% were re-
corded as hyperoxic. For in vivo studies where hyperoxia
was established locally through superfusion, normoxia
was defined as the state where tissue was superfused
with a physiologic salt solution (PSS) equilibrated with
0–5% O2. With these concentrations, supply of oxygen
to tissue by the PSS is limited as much as possible and
occurs predominantly through the microcirculation. In
these studies, hyperoxia was defined as superfusion with
a PSS with an oxygen concentration of > 5%.
In ex vivo studies, partial pressure of oxygen (PO2) is
directly comparable to partial pressure of oxygen in arter-
ial blood (PaO2). Hence, the lower limit of normoxia was
defined as PSS equilibrated with at least 7% O2, which
yields a PO2 of ~ 55 mmHg. Because ex vivo oxygen
exposures are often much higher than attainable in vivo
(e.g. 100% O2 ex vivo gives a PO2 of ~ 760 mmHg, while
inhalation of pure oxygen gives a PaO2 of approximately
350 mmHg), we used measurements at the lowest
non-hypoxic oxygen exposure as the “normoxic” state and
any exposures above as “hyperoxic”.
Data extraction
From each article we extracted data on the species,
strain, age, weight and sex of the animals used, type of
anesthetic used, method and level of oxygen exposure,
type of preparation/measurement setup, buffers used,
descriptions of variability in preparations and oxygen
dose-response relations. Reports on a change in vascular
tone upon exposure to hyperoxia were extracted as
“experiments” (e). Sometimes an experiment was not
supported by data (e.g. data not shown). Experiments
with data were extracted as “data sets” (k). These data
sets include the number of animals/vessels used, mean
and standard deviation or standard error of the vessel
diameter (or equivalent, e.g. tension), or change from
baseline data, during normoxic and hyperoxic exposures.
Data not reported numerically were extracted from
graphs with a digital ruler if possible. Because of incom-
plete outcome data in five studies, we contacted the cor-
responding author by email to request additional
information. We received a response from one author,
who was unable to supply the missing data. If a study re-
ported multiple responses from similar vessels in
separate groups (e.g. different unique control groups),
then only the data from the group with the largest num-
ber of paired vessels were used in this meta-analysis. If
there was uncertainty about the number of observations
(e.g. the number of observations was reported as a
range), the lowest value was used to calculate a conser-
vative estimate of the standard error. All data were ex-
tracted by one author (BS) and then randomly checked
by a second (AS).
Quality assessment
The quality of studies was assessed using a tailor-made
checklist containing ten items regarding blinding, prep-
aration quality, verification of intervention efficacy, se-
lective outcome reporting, description of animals and
arteries, power analysis, ethical approval, conflicts of
interest and peer review. For a list of the criteria used,
see Additional file 2.
Data analysis
All calculations were made using RStudio v1.1.383 and
the “metafor” and “dosresmeta” package (Integrated
Development for R. RStudio, Inc., Boston, USA). Graphs
were made using GraphPad Prism 7.0 (GraphPad
Software, Inc., La Jolla, USA) or RStudio. Effect sizes are
presented as the standardized mean difference (SMD)
for series of experiments involving paired comparisons
as proposed by Gibbons [24]. All statistics are reported
with their 95% confidence interval. An estimation of the
variance of the SMD was done for a one group design
with repeated measures [24]. Missing SDdifference values
were calculated assuming correlation between measure-
ments of 0.7 [25]. A sensitivity analysis using higher and
lower correlation coefficients was conducted to test the
robustness of our results. Effect estimates of the max-
imal hyperoxic exposure were pooled using a random
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effects model. Heterogeneity was assessed by the I2 statis-
tic and is reported with its 95% confidence interval [26].
As a priori sources of heterogeneity we considered ani-
mal species, sex, vascular bed and method of hyperoxia
exposure for in vivo studies. For ex vivo studies, we con-
sidered species, sex, tissue origin of the vessel, vessel type
(systemic or resistance) and the presence of flow. We
added baseline artery diameter post hoc as a possible
source of heterogeneity for in vivo studies. The relation
between effect size and artery diameter was explored
through restricted cubic spline modeling, because it does
not require any assumption on the type of relation be-
tween the two variables (e.g linear, sigmoidal etc.) [27].
The Akaike information criteria (AIC) was used to deter-
mine the optimal number of knots and their position [28].
For each subgroup a minimum of five data sets, from
three unique studies, had to be present. Sources of hetero-
geneity were investigated using meta-regression, by first
performing an overall test for interaction, and if the
P value was <0.05, pairwise comparisons between sub-
groups were made to detect further subgroup interactions.
To correct for multiple testing, P values were adjusted
with the Holms-Bonferroni method.
The likelihood of publication bias was assessed using
the trim and fill method [29]. Because SE-based preci-
sion estimates cause distortion of SMD funnel plots we
used 1/√n as the precision estimate in the trim and fill
analysis [30].
Results
Search and study selection
A flow chart of the study selection process is shown in
Fig. 1. After exclusion based on title and abstract, we iden-
tified 319 articles investigating the relation between oxy-
gen and vascular tone: 261 studies were excluded based
on predefined exclusion criteria. From the 60 included
studies, 42 were performed in live animals and 18 studies
used isolated arteries and arterioles. One study performed
both eligible in vivo and ex vivo experiments [31].
Studies were performed between 1974 and 2017 and the
majority (64%) was published between 1980 and 2000.
Fig. 1 Flowchart describing the inclusion and exclusion of studies. n = number of studies, e = number of experiments described (either with or
without data), k = number of data sets, which are the responses accompanied by data suitable for meta-analysis
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Characteristics of the included studies are presented in
Tables 1 (in vivo studies) and 2 (ex vivo studies).
Study characteristics
In vivo studies
The 42 in vivo studies were carried out in rats (n = 19),
hamsters (n = 17), mice (n = 3), rabbits (n = 3) and cats
(n = 1). In one study both rats and hamsters were used
[32]. Most studies exclusively used male animals (n = 27).
In one study both male and female animals were used, in
one only females were used and in the remaining studies
the sex of animals was not reported. Rats were between 5
and 18 weeks of age and weighed 75–413 g (range of
study averages). Ages were not reported for other animals.
Hamsters weighed 55–200 g, mice 24–35 g, rabbits 3–
4 kg and cats 0.9–1.5 kg. In most studies the animals were
anesthetized with pentobarbital (n = 28, used predomin-
antly in rats and hamsters). Other anesthetics were thio-
pental [33–35], chloralose [36, 37], urethane [37, 38],
ketamine [39] or a mixture of droperidol, midazolam and
fentanyl [40–42]. In some studies skinfold windows were
applied so that the microcirculation could be observed
without anesthesia [14, 43–45].
Each study reported 1–6 experiments in which blood
vessel diameter was observed while hyperoxia was in-
duced. Combined, a total of 69 experiments (e) were de-
scribed in these studies, which included measurements
on arterioles with a median diameter of 20 μm (inter-
quartile range 14–34 μm, 1st to 6th order arterioles) in
the cremaster (e = 20), cheek pouch (e = 16), dorsal skin
(e = 10), sartorius muscle (e = 6), mesoappendix (e = 6),
spinotrapezius muscle (e = 4), ear (e = 2), ileum (e = 2),
retractor muscle (e = 1), sciatic nerve (e = 1) and the
sublingual microcirculation (e = 1). The area of interest
was superfused with a physiologic salt solution, equili-
brated with 0% or 5% O2 (normoxia, e = 52 and e = 4, re-
spectively) and subsequently exposed to 10% (hyperoxia,
e = 9), 21% (e = 46) or 95% O2 (e = 1). In 13 experiments,
blood vessels were observed through a surgically im-
planted window (e = 7, in the cheek pouch or the ear) or
non-invasively by a hand-held device (e = 1), while
hyperoxia was induced systemically by increasing the
fraction of oxygen inspired by the animal (e = 13).
Ex vivo studies
In the 18 ex vivo studies, isolated arteries from rats (n = 7),
pigs (n = 4), rabbits (n = 3), cows (n = 2), mice (n = 1)
and sheep (n = 1) were used. In 10 studies male animals
were used and in one study animals of either sex were
used [15]: in the remaining 7 studies animal sex was
not reported. Rats were 6–15 weeks old and weighed
200–500 g. Pigs were about 4 months old and weighed
70–100 kg. Mice were 10–12 weeks old and weighed
25 g on average. The age and weight of cows and sheep
were not reported.
In these studies, 23 experiments were described. The
maximal diameters of the vessels ranged between 100
and 5000 μm and they were exposed to hyperoxia in
muscle chambers (e = 10), wire myographs (e = 5) and
pressure myographs (e = 8). Both conduit (thoracic aorta,
femoral artery, coronary artery) and resistance arteries
(gracilis arteriole, cremaster arteriole) were investigated.
All studies used physiological salt solutions with com-
parable contents. After isolation, the blood vessels in
some studies spontaneously developed tone [13, 16, 18,
31, 46–50]. Isolated vessels that did not develop tone
were left unconstricted [17, 51–53] or were constricted
to ~ 40–50% of their baseline diameter with norepineph-
rine [16, 54, 55], phenylephrine [56], histamine [15], po-
tassium chloride [15, 18, 55], thromboxane (U46199)
[53], serotonin (5-HT) [53] or prostaglandin F2α [53].
Vessels were exposed to normoxia by gassing the sur-
rounding buffer with 10–21% oxygen. In one study, 40%
oxygen was used in the control group [15]. Hyperoxia
was induced by changing the gas supply to 21% or 95%
O2. In 11 experiments, the authors measured the PO2 of
the solutions, which ranged from 78 to 160 mmHg for
normoxia and 280–617 mmHg for hyperoxia.
Quality assessment
See Fig. 2 for an overview of the quality assessment. Over-
all, the reporting of key quality indicators was poor in
both in vivo and ex vivo studies. Only 2 out of 60 studies
(3%) reported blinding of any phase of the experiment;
these two cases were in vivo studies where the outcome
assessor was blind to the experimental groups. Quality
checks of the preparation were not described in 66% of
the studies and 62% of the studies did not report whether
and how the intervention was verified (e.g. by measuring
PO2 levels). Similarly, the reporting of other preparation
conditions (temperature, CO2 and pH) was insufficient in
79% and 78% of the studies, respectively. Adequate de-
scriptions of relevant details about the animals (e.g. sex,
number of animals used), or vessels (diameters, selection)
were lacking in 70% and 78% of the studies, respectively.
Only one study performed a power analysis. The majority
of studies (66%) were published in peer-reviewed journals,
however, for 4 studies it was unclear whether these were
peer-reviewed. Only 6 studies (10%) provided a conflict of
interest statement and only 24 studies (40%) mentioned
approval by an ethical board.
Descriptive synthesis of outcomes
In vivo effect of hyperoxia on vascular tone
According to the effects reported by the original authors
(Table 1), raising the P(a)O2 to hyperoxic levels resulted
in vasoconstriction in 91% of the studies. In 7% there
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Table 1 In vivo studies
1st Author, year of publication Effect* Species (strain) Organ/tissue Diameter (μm) Vessels (n) Oxygen**
Duling, 1974 [38] ↓ Hamster (GS) Cheek pouch muscle 15 14 0 / 21%
Gorczynski & Duling, 1978 # [61] ↓ Hamster Cremaster muscle 13 3 0 / 10%
Davis et al., 1981 a [85] ↓ Hamster (GS) Cheek pouch muscle 26 6 0 / 20%
Davis et al., 1981 b [85] ↓ Hamster (GS) Cheek pouch muscle 14 6 0 / 20%
Davis et al., 1981 c [85] ↓ Hamster (GS) Cheek pouch muscle 96 6 0 / 20%
Davis et al., 1981 d [85] ↓ Hamster (GS) Cheek pouch muscle 51 6 0 / 20%
Lombard et al., 1981 a [86] ↓ Hamster Cheek pouch muscle 19 10 0 / 10%
Lombard et al., 1981 b [86] ↓ Hamster Cheek pouch muscle 9 7 0 / 10%
Sullivan & Johnson, 1981 a [36] ↓ Cat Sartorius muscle 52 11 0 / 20%
Sullivan & Johnson, 1981 b [36] ↓ Cat Sartorius muscle 35 16 0 / 20%
Sullivan & Johnson, 1981 c [36] ↓ Cat Sartorius muscle 18 10 0 / 20%
Sullivan & Johnson, 1981 d [36] ↓ Cat Sartorius muscle 13 6 0 / 20%
Sullivan & Johnson, 1981 e [36] ↓ Cat Sartorius muscle 9 10 0 / 20%
Sullivan & Johnson, 1981 f [36] ↓ Cat Sartorius muscle 8 12 0 / 20%
Jackson & Duling, 1983 [59] ↓ Hamster (GS) Cheek pouch muscle 32 19 0 / 21%
Lombard & Stekiel, 1985 a [57] ↓ Rat (WS) Mesoappendix 41 16 0 / 21%
Lombard & Stekiel, 1985 b [57] ↓ Rat (WS) Mesoappendix 19 11 0 / 21%
Lombard & Stekiel, 1985 c [57] ↔ Rat (WS) Mesoappendix 11 15 0 / 21%
Jackson, 1986 a [32] ↓ Hamster (GS) Cheek pouch muscle 20 19 0 / 21%
Jackson, 1986 b [32] ↓ Hamster (GS) Cremaster muscle 14 6 0 / 21%
Jackson, 1986 c [32] ↓ Rat (SD) Cremaster muscle 19 8 0 / 21%
Jackson, 1987 [12] ↓ Hamster (GS) Cheek pouch muscle 40 5 0 / 21%
Jackson, 1988 [62] ↓ Hamster (GS) Cheek pouch muscle 31 22 0 / 21%
Lombard & Stekiel, 1988 a [66] ↓ Rat (WKY) Mesoappendix 30 10 0 / 10%
Lombard & Stekiel, 1988 b [66] ↓ Rat (WKY) Mesoappendix 18 15 0 / 10%
Lombard & Stekiel, 1988 c [66] ↓ Rat (WKY) Mesoappendix 10 11 0 / 10%
Jackson, 1989 [63] ↓ Hamster (GS) Cheek pouch muscle 28 19 0 / 21%
Bertuglia et al., 1991 a [43] ↓ Hamster (GS) Dorsal skin 5 20 .21 / 1.0
Bertuglia et al., 1991 b [43] ↓ Hamster (GS) Dorsal skin 7 12 .21 / 1.0
Bertuglia et al., 1991 c [43] ↑ Hamster (GS) Dorsal skin 46 10 .21 / 1.0
Jackson, 1991 [67] ↓ Hamster (GS) Cheek pouch muscle 12 11 0 / 21%
Taguchi et al., 1992 [87] ↓ Rabbit Ear ? 6 .21 / 1.0
Jackson, 1993 a [64] ↓ Hamster (GS) Cremaster muscle 16 22 0 / 21%
Jackson, 1993 b [64] ↓ Hamster (GS) Cheek pouch muscle 20 15 0 / 21%
Rafi & Boegehold, 1993 a [33] ↓ Rat (SS/Jr) Spinotrapezius 29 13 0 / 10%
Rafi & Boegehold, 1993 b [33] ↓ Rat (SS/Jr) Spinotrapezius 17 17 0 / 10%
Rafi & Boegehold, 1993 c [33] ↓ Rat (SS/Jr) Spinotrapezius 9 16 0 / 10%
Pries et al., 1995 [88] ↓ Rat (SD) Spinotrapezius 35 18 0 / 20%
Dewhirst et al., 1996 [58] ↔ Rat (F344) Dorsal skin 47 6 .21 / 1.0
Harder et al., 1996 [89] ↓ Rat (SD/WS) Cremaster muscle 21 8 0 / 5%
Welsh et al., 1998 [60] ↓ Hamster (GS) Cheek pouch muscle 52 17 0 / 21%
Lombard et al., 1999 a [90] ↓ Hamster (GS) Cremaster muscle 19 19 0 / 21%
Lombard et al., 1999 b [90] ↓ Hamster (GS) Retractor 22 11 0 / 21%
Lombard et al., 1999 c [90] ↓ Hamster (GS) Cheek pouch muscle 21 10 0 / 21%
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was no effect on arteriolar diameter [35, 57, 58] and in
one study dilation of second order arterioles was ob-
served [43]. The median diameter change was − 20%
with a range of − 64% to + 6%.
Ex vivo effect of hyperoxia on vascular tone
Including the experiments without data, hyperoxic vaso-
constriction was seen in 59% of the reports. In 23% there
was no change in arteriolar diameter [15, 16, 51, 53] and
in 18% dilation was observed [15, 17, 18, 52]. In the
studies that reported diameters [13, 16, 47–50], the me-
dian change was − 14% with a range of − 24% to − 1%.
Experimental difficulties
Some articles explicitly mentioned difficulties encoun-
tered during the experiments and variation in responses
between separate vessels. In vivo, a vasomotor response
to changes in oxygen exposure was not observed in 12%
[38], 25% [59] and 40% [42] of the animals. The authors
did not provide an explanation for non-responsiveness
in these animals. In two studies, 26–50% of the vessels
failed to return to their stable baseline diameter after the
first exposure to hyperoxia [41, 60].
Ex vivo, one study described that only 32% of the iso-
lated arteries responded to oxygen [59]. In addition, in
reactive vessels, the constriction to oxygen disappeared
after 2–6 oxygen exposure cycles. The author con-
cluded that the lack of oxygen reactivity was not an
indication of vessel damage, because both responding
and non-responding vessels developed spontaneous
tone and had similar responses to norepinephrine. In
porcine coronary arteries, repeated exposures to
Table 1 In vivo studies (Continued)
1st Author, year of publication Effect* Species (strain) Organ/tissue Diameter (μm) Vessels (n) Oxygen**
Frisbee & Lombard, 1999 [69] ↓ Rat (SD) Cremaster muscle 20 12 0 / 21%
Frisbee & Lombard, 2000 [91] ↓ Rat (SD) Cremaster muscle 17 12 0 / 21%
Frisbee et al., 2000 [92] ↓ Rat (WKY) Cremaster muscle 18 6 0 / 21%
Sauls & Boegehold, 2000 [34] ↔ Rat (SD) Ileum 63 11 5 / 21%
Komori et al., 2001 [68] ↓ Rabbit (Albino) Ear nr 11 .21 / 1.0
Kunert et al., 2001 a [73] ↓ Rat (SD) Cremaster muscle nr 16 0 / 21%
Kunert et al., 2001 b [72] ↓ Rat (WKY) Cremaster muscle nr 26 0 / 21%
Sauls & Boegehold, 2001 [35] ↔ Rat (SD) Ileum 62 17 5 / 21%
Frisbee, 2002 [11] ↓ Rat (SD) Cremaster muscle 22 12 0 / 21%
Frisbee & Lombard, 2002 [31] ↓ Rat Cremaster muscle 102 12 0 / 21%
Tsai et al., 2003 a [45] ↓ Hamster (GS) Dorsal skin 59 18 .21 / 1.0
Tsai et al., 2003 b [45] ↓ Hamster (GS) Dorsal skin 25 15 .21 / 1.0
Tsai et al., 2003 c [45] ↓ Hamster (GS) Dorsal skin 10 15 .21 / 1.0
Tsai et al., 2003 d [45] ↓ Hamster (GS) Dorsal skin 6 15 .21 / 1.0
Drenjancevic et al., 2004 a [65] ↓ Rat (RGRR) Cremaster muscle 19 8 5 / 21%
Drenjancevic et al., 2004 b [65] ↓ Rat (Dahl) Cremaster muscle 22 8 5 / 21%
Cabrales et al., 2006 [44] ↓ Hamster (GS) Dorsal skin 58 26 .21 / 1.0
Sakai et al., 2007 [37] ↓ Rat (WS) Sciatic nerve 26 8 0 / 21%
Kunert et al., 2009 [93] ↓ Rat (SD) Cremaster muscle 23 18 0 / 21%
Wang et al., 2009 [94] ↓ Rat (Dahl SS) Cremaster muscle 16 9 0 / 21%
Ngo et al., 2010 [41] ↓ Mouse (C57) Cremaster muscle 29 6 0 / 21%
Riemann et al., 2010 [42] ↓ Mouse (C57) Cremaster muscle 31 7 0 / 95%
Messmer et al., 2012 [14]ǂ ↔ Hamster (GS) Dorsal skin nr ? .21 / 1.0
Ngo et al., 2013 [40] ↓ Mouse (C57) Cremaster muscle 33 28 0 / 21%
Milstein et al., 2016 [39] ↓ Rabbit (NZW) Sublingual 4 40 .21 / 1.0
Studies are sorted based on year of publication
Abbreviations: NZW New Zealand White, SD Sprague Dawley, WS Wistar, LY Landrace Yorkshire, M muscle chamber, W wire myograph, P pressure myograph, nr
not reported
*Effect as reported by the original paper, arrows indicate the direction of the change in diameter
**A value suffixed with a “%” symbol indicates the percentage of oxygen used to oxygenate the physiological salt solution; other values indicate the fraction of
inspired oxygen
#Not included in the meta-analysis due to a small number of observations or because no data was shown (ǂ)
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hyperoxia also decreased the magnitude of hyperoxic
vasoconstriction.
Dose-response studies
Dose-response relationships were examined in 16 in vivo
studies: 10 of these used three oxygen concentrations [39,
41, 57, 61–67] (including reference level), in four studies
four levels of oxygen were used [59, 68, 69] and in two
studies five different oxygen concentrations were used [11,
31]. In the majority of these studies, 20–21% oxygen in
the superfusion buffer was the maximal exposure, while
one study also used 95% oxygen [59]. Intermediate oxygen
concentrations were 5%, 7% or 10% oxygen. In studies
with more than three different oxygen doses, the relation-
ship between diameter changes and oxygen concentration
was approximated as sigmoidal [11], exponential [59, 68]
or linear [31, 69]. In general, arteriolar diameter decreased
as the oxygen concentration increased, without any appar-
ent threshold dose. Only in one study, in which the rela-
tionship seemed sigmoidal [11], no constriction
occured until the oxygen concentration in the superfusion
buffer was increased above 5%.
Of the ex vivo studies, eight studies used a total of
three [18, 31, 47, 49], four [16, 50, 70] or five [55] oxy-
gen concentrations (including reference level). The range
of oxygen exposure assessed varied between 10 and 21%
to 10–95%. In all studies except for two, a decrease in
diameter was seen as the oxygen concentration in-
creased. The dose-response relationships in studies with
more than three levels of exposure were described as lin-
ear in the normoxic-hyperoxic range [16, 55, 70, 71]. In
one study there was no discernable difference between
40% or 95% O2 [18] and in another there was no effect
at any oxygen concentration (10–95% O2) [16].
Table 2 Ex vivo studies
1st Author Effect* Species (strain) Artery Type Tone Model Diameter (μm) Vessels (n) Oxygen**
Chang & Detar, 1980 [54] ↓ Rabbit (NZW) Aorta Conduit Norepinephrine M 4000–5000 10 100 / 300
Pittman & Graham,
1986 a [55]ǂ
↓ Rabbit (NZW) Aorta Conduit Norepinephrine M nr ? ±100 / 280
Pittman & Graham,
1986 b [55]ǂ
↓ Rabbit (NZW) Aorta Conduit KCl M nr ? ±100 / 280
Vallet et al., 1994 [56] ↓ Rat (SD) Aorta Conduit Phenylephrine M 2200–2800 6 20 / 95%
Day et al., 1992 [51] ↔ Rabbit (NZW) Aorta Conduit None W nr 6 160 / 495
Kwan et al., 1989 [52] ↑ Sheep Coronary Conduit None M 600–2500 8 12 / 95%
Ngai et al., 1990 [17] ↑ Pig Coronary Conduit None M nr 10 20 / 95%
Rubanyi & Paul, 1984 b [15] ↑ Pig Coronary Conduit Histamine M nr 6 40 / 95%
Rubanyi & Paul, 1985 [18] ↑ Pig Coronary Conduit Spontaneous/KCl M 1500–2000 10 12 / 95%
Hedegaard et al., 2011 [70] ↓ Pig (LY) Coronary Conduit PGF2a W nr 9 10 / 95%
Kalsner, 1976 [46] ↓ Cow Coronary Conduit Spontaneous M nr 14 112 / 515
Pasgaard et al., 2007 b [53] ↓ Pig Coronary Conduit U46199 W nr 14 120 / 617
Pasgaard et al., 2007 c [53] ↓ Pig Coronary Conduit 5-HT W nr 7 120 / 617
Pasgaard et al., 2007 a [53] ↔ Pig Coronary Conduit None W nr ? 120 / 617
Rubanyi & Paul, 1984 a [15]ǂ ↔ Cow Coronary Conduit KCl M nr ? 40 / 95%
Frisbee & Lombard, 2002 [31]# ↓ Rat Cremaster Resistance Spontaneous P 140 12 10 / 21%
Messina et al., 1994 [13] ↓ Rat (WS) Cremaster Resistance Spontaneous P 163 27 21 / 95%
Smit et al., 2017 b [16] ↔ Mouse (C57) Femoral Conduit Norepinephrine P 293 16 78 / 375
Fredricks et al., 1994 [47] ↓ Rat (SD) Gracilis Resistance Spontaneous P 100–300 7 87 / 148
Frisbee et al., 2001 [48] ↓ Rat (SD) Gracilis Resistance Spontaneous P 185 15 15 / 95%
Frisbee et al., 2002 [49] ↓ Rat (SD) Gracilis Resistance Spontaneous P 194 76 10 / 21%
Liu et al., 1997 [50] ↓ Rat (SD) Gracilis Resistance Spontaneous P nr 6 10 / 21%
Smit et al., 2017 a [16] ↔ Mouse (C57) Gracilis Resistance Spontaneous P 129 22 78 / 375
Studies are sorted based on artery, effect and first author
Abbreviations: NZW New Zealand White, SD Sprague Dawley, WS Wistar, LY Landrace Yorkshire, M muscle chamber, W wire myograph, P pressure myograph, nr
not reported
*Effect as reported by the original paper; arrows indicate the direction of the effective change in diameter
**A value suffixed with a “%” symbol indicates the percentage of oxygen used to oxygenate the physiological salt solution, other values indicate the oxygen
tension in mmHg
ǂNot included in the meta-analysis because no data was shown or values could not be recalculated (#). For diameters, values are presented as range or
average diameter
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Meta-analysis
In vivo studies
Out of the 69 experiments, 67 (k = 67) were included in
the meta-analysis of in vivo studies. Two could not be
included because in one study only three vessels were
observed [61] and in another the data were not shown
[14]. Overall, there was a significant vasoconstrictor ef-
fect of hyperoxia on arteries in vivo (SMD − 1.42 (− 1.65
to − 1.19), Fig. 3); heterogeneity between studies was
high (I2 72% [62–85]).
Ex vivo studies
Out of the 23 experiments, 18 (k = 18) were included in
the meta-analysis of ex vivo studies. Four experiments
were mentioned in the text but were not accompanied
by data [15, 53, 55] and one paper reported normalized
data for one experiment that could not be appropriately
recalculated [31]. Overall, there was a borderline signifi-
cant vasoconstrictor effect of hyperoxia on arteries ex
vivo (SMD − 0.56 (− 1.09 to − 0.03), P = 0.04, Fig. 4).
Between-study heterogeneity was high (I2 88% [80–87]).
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11. Is there a conflict of interest statement?
10. Was the study approved by an ethical board?
9. Is the study published in a peer reviewed journal?
8. Were group sizes based on a power analysis?
7. Were the vessels properly described?
6. Were the animal characteristics properly described?
5. Was there no selective outcome reporting?
4. Did the authors verify temperatures, pH and CO2?
3. Did the authors verify the intervention?
2. Was the preparation checked for stability and quality?
1. Were the assessors/data analysts blinded?
Ex vivo studies
Proportion of studies (%)
No
Yes
Unclear
0% 25% 50% 75% 100%
11. Is there a conflict of interest statement?
10. Was the study approved by an ethical board?
9. Was the study published in a peer reviewed journal?
8. Were group sizes based on a power analysis?
7. Were the vessels properly described?
6. Were the animal characteristics properly described?
5. Was the study free of selective outcome reporting?
4. Did the authors verify temperatures, pH and CO2?
3. Did the authors verify the intervention?
2. Was the preparation checked for stability and quality?
1. Were the assessors/data analysts blinded?
In vivo studiesa
b
Fig. 2 Quality assessment scores for in vivo studies (a) and ex vivo studies (b)
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Fig. 3 In vivo studies on the effect of hyperoxia on arteriolar diameter, sorted by effect size
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Exploring sources of heterogeneity
In vivo studies
Subgroup analyses were only conducted in groups with
five or more experiments from at least three unique stud-
ies. For the in vivo studies, subgroup analyses were con-
ducted for species (rat and hamster, Fig. 5), vascular
region (dorsal skin, intestines, cremaster muscle, cheek
pouch, Fig. 5), method of hyperoxia induction (systemic
by increasing the percentage of oxygen in the inspired air,
Fig. 5) and vessel diameter (Fig. 6). Sex could not be exam-
ined because the studies mostly used male animals or did
not specifically report animal sex. Species did not modify
the overall effect (P = 0.83). Vascular region interacted
with the overall effect (P < 0.001). P values for further
pairwise comparisons were adjusted with the Holms-
Bonferroni method. Moderators that increased the effect
size of hyperoxic constriction were the cremaster as a vas-
cular region (Pholm < 0.001). This subgroup explained 53%
of the heterogeneity (R [2]) in the overall effect. A smaller
response was seen in studies in which the dorsal skin
(Pholm = 0.033, R
2 = 10%) or the intestines was investigated
(mesoappendix and ileum, Pholm = 0.033, R
2 = 19%). The
effect size was not different in studies that induced hyper-
oxia systemically (Pholm = 0.061, R
2 = 7%). In a weighted
four-knot restricted cubic spline meta-regression, artery
diameter accounted for 16% of the observed heterogeneity
(P = 0.008, Fig. 6).
Ex vivo studies
In the ex vivo studies, only two species were used in a
sufficient number of studies to be considered as sub-
groups (pigs and rats). Other potential sources of het-
erogeneity investigated were type of artery (conduit or
resistance arteries) and vessel origin (gracilis and coron-
ary arteries). Coincidentally, all conduit arteries were
examined in tension myographs, while resistance arteries
were mounted in pressure myographs. Hence, results of
an analysis based on the method used to mount the iso-
lated arteries would be the same as now presented based
on the type of artery. There were not sufficient studies
reporting sex or using flow to analyze as subgroups. Of
the investigated subgroups, none explained a significant
proportion of the heterogeneity (Fig. 7).
Publication bias and sensitivity analysis
The funnel plot for the in vivo studies shows an indica-
tion of publication bias, favoring studies that reported
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constriction of arterioles upon exposure to hyperoxia
(Additional file 3). Balancing the results with the trim
and fill method reduced the overall effect size (P = 0.03)
from − 1.42 (− 1.65 to − 1.19) to − 1.03 (− 1.30 to − 0.76).
The funnel plot for the ex vivo studies did not reveal
evidence of publication bias (Additional file 3).
For all analyses shown, we used a conservative correl-
ation coefficient of 0.7 to impute missing standard devia-
tions of paired data. Missing standard deviations had to
be calculated for 21/67 in vivo data sets and 7/18 ex vivo
data sets. Using a higher or lower correlation coefficient
did not affect the results for the in vivo analysis
(Additional file 4). For the ex vivo analysis, the differ-
ences were marginal, but when a low correlation
coefficient of 0.5 was used, the confidence interval of the
overall effect crossed zero.
Discussion
In this systematic review and meta-analysis, we found
that normobaric hyperoxia or hyperoxic superfusion de-
creases the diameter of in vivo arteries and arterioles, in
comparison to normoxia or normoxic superfusion, indi-
cating an increase in vascular tone. For ex vivo studies,
our meta-analysis shows a smaller effect of hyperoxia
decrease in isolated vessel tone. Both vasodilation, vaso-
constriction and neutral effects were observed, for which
the explanation is unclear. In contrast, in the intact ani-
mal hyperoxia almost exclusively causes vasoconstriction
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(median − 20% reduction in diameter), which was most
pronounced in the cremaster vasculature but less in the
intestinal and skin vasculature. In a post-hoc analysis,
the magnitude of hyperoxic vasoconstriction showed a
U-shaped curve and was highest in vessels of 15–25 μm
in diameter. There seems to be no oxygen threshold for
the constriction to occur.
There was a large difference in effect size between the in
vivo and ex vivo studies. The existence of a branching
order-specific effect, i.e. confinement of hyperoxic vaso-
constriction to smaller arterioles, could be one explanation
for this difference. We found that oxygen-induced con-
striction was the largest in arteries of 15–25 μm in diam-
eter and less in arteries with diameters above and below
this range. The arteries used in the ex vivo studies were all
considerably larger than the vessels examined in vivo, ran-
ging between 100 μm and 5000 μm ex vivo, versus
4–100 μm in vivo. The difference in size between the in-
vestigated arteries is the result of a practical limitation,
considering that it is very difficult to isolate and mount
small arteries without damaging the vessel ex vivo. The re-
duced effect of hyperoxia on arteries < 20 μm may be ex-
plained by the decreasing presence of vascular smooth
muscle and thus the ability to constrict. Another explan-
ation is that the mechanism responsible for hyperoxic
vasoconstriction is primarily located in extravascular tis-
sue, rather than in the vessel wall. For example, the
CYP450 omega hydroxylases, which can produce the vaso-
constrictor 20-hydroxyeicosatetraenoic acid (20-HETE)
from arachidonic acid, is found in cremaster arterioles, but
is also highly expressed in the surrounding muscle tissue
[72, 73]. Hence, for substantial (measurable) hyperoxic
vasoconstriction, extravascular tissue may be required.
We found regional differences in the magnitude of
hyperoxic constriction between the intestine, skin and
cremaster muscle. The differences are likely related to
intrinsic differences in blood vessels between vascular
beds, or presence of multiple mechanisms that regulate
vascular tone. For instance, 20-HETE constricts arteries
in the cremaster and gracilis muscle but dilates mesen-
teric arteries [74]. Inhibition of nitric oxide in intestinal
arteries only temporarily reduces vessel diameter [35],
which suggests that in these vessels the impediment of
one vasoactive system is quickly compensated by an-
other. The same might be true for the pathway affected
by hyperoxia. The reduced effect in skin could be related
to the already low basal perfusion of skin at room
temperature, so that any further reductions in flow and
artery diameter are prevented by other mechanisms,
such as temperature control [75]. In humans, hyperoxia
has no effect on skin flow, unless first pharmacologically
raised or measured in existing high-flow areas. Because
control of body temperature is a major aspect of skin
perfusion, the pathway for temperature control could
take precedence over the oxygen sensor. The exact
mechanism behind hyperoxic vasoconstriction has not
yet been determined. Potential pathways include a re-
duction in nitric oxide bioavailability due to increased
reactive oxygen species production, decreased produc-
tion of prostaglandins, increased production of 20-HETE
and interaction with calcium and potassium channels.
The varying results may not necessarily be conflicting
but could be simply due to differences in vascular beds
and locations in the arterial tree.
This meta-analysis shows that hyperoxia in vivo causes
a relatively increased level of vasoconstriction in muscle
(i.e. cremaster and cheek pouch). Although perfusion of
skeletal muscle is arguably not a priority in the critically
ill, a restriction of blood flow in cardiac muscle may be
detrimental. In one trial, hyperoxia led to increased
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infarct size in patients with myocardial infarction [76];
this may have been the result of decreased perfusion,
considering that in pigs, hyperoxic coronary vasocon-
striction leads to increased tissue hypoxia in areas with
acute coronary stenosis [77]. The reduced constriction
observed in the intestinal region could be of clinical im-
portance. Organs with relatively reduced hyperoxic con-
striction will receive a larger portion of the cardiac
output. This has been observed in hemodiluted dogs,
pigs with peritonitis and rats with hemorrhagic shock,
where hyperoxia caused a redistribution of the cardiac
output towards vital organs such as the kidney, liver and
intestines [4, 5, 78]. In rats, hyperoxia was shown to re-
duce bowel injury after ischemia and reperfusion of the
mesentery [79]. Because of the relative increase in perfu-
sion, hyperoxia may thus be beneficial for patients with
splanchnic hypoperfusion.
Vessel diameter has a dominant influence on blood flow.
In vivo, the median hyperoxia-induced decrease in diam-
eter was 20%, which, using Poiseuille’s law, leads to a re-
duction of approximately 60% in flow. Following the
dose-response studies, the constrictor effect of oxygen oc-
curs at any level above normoxia, meaning that any level
of hyperoxia will have consequences for organ blood flow
if vasoconstriction occurs. However, the translatability of
these effects to clinical practice is difficult. The effect of
oxygen on artery diameter depends on oxygen tension,
which was rarely measured in the included studies. The
oxygen percentages used in superfusion buffers cannot be
directly converted to a fraction of inspired oxygen. Sec-
ond, in the majority of the in vivo studies, both the arter-
ies and tissue were exposed to the hyperoxic oxygen
tensions, meaning that the oxygen delivery was no longer
solely facilitated by blood flow. Any tissue-derived signals
generated by the reduction in blood flow may therefore
have been missed, confounding the results.
Human hyperoxic coronary vasoconstriction is a
well-documented phenomenon and has been observed
directly by means of angiography [80, 81] and indirectly
via increases in coronary vascular resistance measure-
ments [80, 82–84]. Surprisingly however, results of ex
vivo studies of the isolated coronary circulation are less
univocal. Of the eight experiments with coronary vessels,
vasoconstriction to increased oxygen tensions was seen
in four, while vasodilation was observed in the other
four. Differences could again be related to vessel size. In
the studies in which coronary constriction was observed,
arteries were mounted in wire myographs, which are
suitable for vessels measuring > 100 μm. Unfortunately,
these studies did not report vessel diameter. However,
the studies in which dilation was seen used muscle
chambers, which are generally used for large arteries.
Two of these studies reported diameter, which ranged
between 0.6 and 5 mm. Another important consideration
is that constriction was only seen with certain types of
preconstriction. This was especially apparent in one
study where coronary preparations were used without
preconstriction or were constricted with serotonin
(5HT) or thromboxane (U46619) analogues [53].
Hyperoxia had no effect on vessels without preconstric-
tion, while a considerable hyperoxic constriction was
seen in the precontracted vessels. Taken together; vessel
preparation may be particularly important in ex vivo
experiments and the use of isolated vessels may not be
appropriate to study the complex vascular responses to
hyperoxia.
Limitations of this review and included studies
There are several limitations to this meta-analysis. There
was considerable heterogeneity between the in vivo stud-
ies, which could only in part be explained by differences
in the region of interest and the size of the vessels investi-
gated. For the ex vivo studies we did not find an explan-
ation for the heterogeneity, suggesting the importance of a
yet unidentified methodological, systemic or metabolic
factor. Second, the funnel plots indicated publication bias
for in vivo studies, favoring studies finding vasoconstric-
tion in response to hyperoxia. However, correction with
the trim and fill method did not significantly alter the con-
clusions. Third, due to the relatively small number of
studies, some collinearity between the investigated sub-
groups may be present. Fourth, for some studies we had
to make an assumption on the correlation coefficient to
impute missing standard deviations. Our conservative esti-
mate may have underestimated the effect, although our
sensitivity analysis shows that using a higher correlation
coefficient did not significantly alter the results. Fifth, all
studies were performed with healthy animals; studies in
disease models may give different results. Similarly, the
use of live animals required the application of anesthetics
in the majority of studies. Most of these drugs have at
least some vasodilatory effects, which may have influenced
the results. However, because of the pre-post design of the
included studies, the effect of the anesthetic is anticipated
to be the same under each oxygen condition. Sixth, we ex-
cluded studies on the lung, retinal and brain vasculature.
Finally, as reflected by our quality assessment of the
included studies, the overall quality of the included stud-
ies was poor, which seriously hampers drawing reliable
conclusions from the included animal studies. Baseline
characteristics of animals were insufficiently described.
Similarly, only 14 of the 60 studies properly described
artery characteristics, such as vessel diameter and selec-
tion of vessels in the arterial tree. Reporting these data is
important to increase reproducibility between studies.
Similarly, measurement of PO2, pH, PCO2 and
temperature was not (sufficiently) performed in the
majority of studies. These measurements are crucial
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because of the dose response relationship between PO2
and hyperoxic vasoconstriction, and the effect of pH,
PCO2 and temperature on vascular tone. Without meas-
uring PO2 the true intervention applied to the vasculature
is unknown, which will contribute to heterogeneity. The
lack of blinding in most studies may have led to an over-
estimation of the true effect. Another flaw in most studies
is the absence of power calculations. Especially for studies
aimed at discovering mechanisms responsible for
oxygen-related changes in vessel diameter, a minimum
predefined number of vessels is necessary to be able to
draw objective statistical conclusions. The majority of the
included studies were conducted before the institution of
more rigorous legislation on the use of animals in scien-
tific procedures known today. The overall poor quality of
studies is therefore likely related to the absence of an eth-
ical board reviewing the studies prior to their execution.
Similarly, the same papers were published before editors
put certain requirements on the reporting of study data.
We have noted that the more recent papers were of con-
siderably higher quality, which shows that the change in
procedures concerning animal research, which are now
becoming very similar to human trials in terms of ethical
board review and data transparency, is for the better.
The majority of the in vivo studies were performed on
thin, externalizable skeletal muscle. Studies in other crit-
ical visceral organs (e.g. liver, kidney) are currently lacking.
We propose that future, high-quality studies focus on vis-
ceral organs such as the kidney and liver. These organs
are highly relevant for patient care and the results will
contribute to the rationale behind selective induction or
avoidance of hyperoxia in certain types of patients.
Conclusions
In this meta-analysis of in vivo and ex vivo studies investi-
gating the effect of hyperoxia on arteriolar diameter, we
found a substantially larger effect size in vivo than ex vivo.
The degree of the constriction is most pronounced in ves-
sels of approximately 15–25 μm in diameter and is pro-
portional to the level of hyperoxia. The vasculature of the
intestines and skin seem less sensitive to hyperoxic vaso-
constriction than skeletal muscle. Ex vivo, the response of
the coronary vasculature to hyperoxia is highly variable.
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